Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Hexaware Technologies is a buying opportunity. The stock has gone through a deep correction and that correction is over. I am looking this stock on the long side from Monday onwards."
"Sun Pharmaceutical Industries has gone through a correction and that correction is over, a consolidation has broken out. Good stocks will become better and better. Sun Pharma is likely to be one of them. A nice speculative buy is Hexaware and a far more conservative buy is Sun Pharma," he added. Also Read: Sun, Merck sign patent licensing agreement for Januvia
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
